Bank of America’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-500
Closed -$72 8309
2023
Q4
$72 Sell
500
-300
-38% -$47 ﹤0.01% 7449
2023
Q3
$140 Sell
800
-5,308
-87% -$6.59K ﹤0.01% 7443
2023
Q2
$19.1K Buy
6,108
+4,381
+254% +$13K ﹤0.01% 6720
2023
Q1
$4.42K Buy
1,727
+767
+80% +$1.58K ﹤0.01% 7094
2022
Q4
$1.43K Buy
960
+60
+7% +$97 ﹤0.01% 7288
2022
Q3
$2K Sell
900
-2,019
-69% -$2.85K ﹤0.01% 7602
2022
Q2
$3K Sell
2,919
-1,907
-40% -$3.27K ﹤0.01% 7731
2022
Q1
$12K Sell
4,826
-9,718
-67% -$25.3K ﹤0.01% 7687
2021
Q4
$67K Sell
14,544
-4,379
-23% -$14.5K ﹤0.01% 7072
2021
Q3
$154K Sell
18,923
-6,221
-25% -$53.3K ﹤0.01% 6475
2021
Q2
$247K Buy
25,144
+2,219
+10% +$18K ﹤0.01% 5954
2021
Q1
$202K Sell
22,925
-5,492
-19% -$60.3K ﹤0.01% 6035
2020
Q4
$291K Buy
28,417
+15,150
+114% +$166K ﹤0.01% 5361
2020
Q3
$120K Buy
13,267
+3,530
+36% +$28K ﹤0.01% 5591
2020
Q2
$69K Buy
9,737
+6,555
+206% +$69.6K ﹤0.01% 5842
2020
Q1
$31K Buy
3,182
+1,973
+163% +$25.4K ﹤0.01% 6036
2019
Q4
$16K Buy
+1,209
New +$14.7K ﹤0.01% 6551

Other funds holding GRTX

Bank of America's GRTX Position: Q1 2024 in Review

Bank of America sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 500 shares — an estimated $72 sold.

Bank of America first reported a position in GRTX in Q4 2019 and held it in 17 quarters. The position peaked at $291K in Q4 2020. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

  • Bank of America reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 500 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $72.
  • Bank of America first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Bank of America's Galera Therapeutics, Inc. Common Stock position peaked at $291K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.